• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估18F FDG PET-CT在塞尔维亚诺维萨德早期宫颈癌术前分期中的疗效——一项试点研究

Assessing the Efficacy of 18F FDG PET-CT in Preoperative Staging of Early-Stage Cervical Cancer in Novi Sad, Serbia-A Pilot Study.

作者信息

Malenković Goran, Malenković Jelena, Tomić Sanja, Šljivo Armin, Tomić Slobodan

机构信息

Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.

ASA Institute for Research and Development and Innovation, 71 000 Sarajevo, Bosnia and Herzegovina.

出版信息

J Clin Med. 2024 Dec 6;13(23):7445. doi: 10.3390/jcm13237445.

DOI:10.3390/jcm13237445
PMID:39685903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11642279/
Abstract

: This study primarily aims to evaluate the preoperative staging effectiveness of PET-CT in early-stage cervical cancer, particularly, its ability to detect primary tumors and micrometastases. : In this retrospective study, cervical cancer patients who had undergone preoperative 18F FDG PET-CT scans and were treated at the Department of Gynecology, Institute of Oncology, Vojvodina, in Sremska Kamenica, during the period from 2016 to 2020 were analyzed. : The study included 62 patients (mean age, 49.3 ± 9.6 years). Squamous cell carcinoma was the predominant histological type (95.2%), with G2 differentiation (82.3%) and FIGO stage Ib1 (80.6%) being the most common. Assessed by 18F FDG PET-CT, the mean tumor size was 26.4 ± 10.8 mm, which is slightly lower than the 26.9 mm measured during clinical examination ( = 0.784), with a significant (r = 0.678, < 0.001) correlation between these methods. 18F FDG PET-CT demonstrated an overall accuracy of 88.7% for identifying primary tumors, with a sensitivity of 86.8%, specificity of 100.0%, PPV of 100.0%, and NPV of 56.2%. An intraoperative examination showed identical overall accuracy but higher sensitivity (98.1%) and lower specificity (33.3%). For 18F FDG PET-CT, the level of agreement with the histopathological examination was good (Kappa 0.656), while for the intraoperative examination, it was moderate (Kappa 0.409). Regarding the lymph node assessment, 18F FDG PET-CT's accuracy was 82.2%, with a sensitivity of 53.8% and a specificity of 89.8%. The intraoperative examination showed lower accuracy (66.1%) but higher sensitivity (76.9%). The 18F FDG PET-CT Kappa value indicated moderate agreement (0.449), while the intraoperative examination showed poor agreement (0.282). : In conclusion, significant effectiveness is shown by 18F FDG PET-CT for preoperative staging of early-stage cervical cancer, offering superior accuracy in detecting primary tumors and micrometastases, particularly in predicting lymph node metastases, thereby enhancing diagnostic accuracy and informing treatment decisions.

摘要

本研究主要旨在评估PET-CT在早期宫颈癌术前分期中的有效性,尤其是其检测原发性肿瘤和微转移的能力。

在这项回顾性研究中,分析了2016年至2020年期间在斯雷姆斯卡卡梅尼察的伏伊伏丁那肿瘤研究所妇科接受术前18F FDG PET-CT扫描并接受治疗的宫颈癌患者。

该研究纳入了62例患者(平均年龄49.3±9.6岁)。鳞状细胞癌是主要的组织学类型(95.2%),最常见的是G2分化(82.3%)和FIGO Ib1期(80.6%)。通过18F FDG PET-CT评估,肿瘤平均大小为26.4±10.8 mm,略低于临床检查测量的26.9 mm(t = 0.784),这两种方法之间存在显著相关性(r = 0.678,P < 0.001)。18F FDG PET-CT识别原发性肿瘤的总体准确率为88.7%,敏感性为86.8%,特异性为100.0%,阳性预测值为100.0%,阴性预测值为56.2%。术中检查显示总体准确率相同,但敏感性更高(98.1%),特异性更低(33.3%)。对于18F FDG PET-CT,与组织病理学检查的一致性水平良好(Kappa 0.656),而对于术中检查,一致性为中等(Kappa 0.409)。关于淋巴结评估,18F FDG PET-CT的准确率为82.2%,敏感性为53.8%,特异性为89.8%。术中检查显示准确率较低(66.1%),但敏感性较高(76.9%)。18F FDG PET-CT的Kappa值表明一致性中等(0.449),而术中检查显示一致性较差(0.282)。

总之,18F FDG PET-CT在早期宫颈癌术前分期中显示出显著有效性,在检测原发性肿瘤和微转移方面具有更高的准确性,特别是在预测淋巴结转移方面,从而提高诊断准确性并为治疗决策提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bef/11642279/b32b910bb178/jcm-13-07445-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bef/11642279/b32b910bb178/jcm-13-07445-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bef/11642279/b32b910bb178/jcm-13-07445-g001.jpg

相似文献

1
Assessing the Efficacy of 18F FDG PET-CT in Preoperative Staging of Early-Stage Cervical Cancer in Novi Sad, Serbia-A Pilot Study.评估18F FDG PET-CT在塞尔维亚诺维萨德早期宫颈癌术前分期中的疗效——一项试点研究
J Clin Med. 2024 Dec 6;13(23):7445. doi: 10.3390/jcm13237445.
2
Comparative Diagnostic Value of 18F-FDG-PET-CT and Intraoperative Examination in Cervical Cancer Staging.18F-FDG-PET-CT 与术中检查在宫颈癌分期中的比较诊断价值。
Medicina (Kaunas). 2024 Oct 26;60(11):1758. doi: 10.3390/medicina60111758.
3
18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.18F-FDG-PET/CT在早期宫颈癌的初始分期中价值有限。
Abdom Imaging. 2015 Jan;40(1):127-33. doi: 10.1007/s00261-014-0194-x.
4
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients.在膀胱癌患者根治性膀胱切除术前使用 18F-氟代-2-脱氧-D-葡萄糖(18F-FDG)PET/CT 进行淋巴结评估。
BJU Int. 2024 Oct;134(4):636-643. doi: 10.1111/bju.16363. Epub 2024 Apr 15.
5
Primary staging with 2[18F]-FDG-PET/CT and -PET/MRI and radiotherapy response evaluation with MRI in uterine cervical cancer: an interim analysis of a prospective clinical trial.2-[18F]-FDG-PET/CT和PET/MRI用于子宫颈癌的初始分期以及MRI用于放疗反应评估:一项前瞻性临床试验的中期分析
EJNMMI Rep. 2025 Jan 10;9(1):3. doi: 10.1186/s41824-024-00236-2.
6
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.18F-FDG PET与CT/MRI在口腔鳞状细胞癌中的应用:一项对124例患者进行组织学相关性分析的前瞻性研究
J Nucl Med. 2005 Jul;46(7):1136-43.
7
Correlation of preoperative 18F-FDG-PET/CT tumor staging and maximum standardized uptake values with preoperative CT, postoperative tumor classification, and histopathological parameters of oral squamous cell carcinoma.术前18F-FDG-PET/CT肿瘤分期及最大标准化摄取值与口腔鳞状细胞癌术前CT、术后肿瘤分级和组织病理学参数的相关性
Clin Oral Investig. 2025 Mar 18;29(4):189. doi: 10.1007/s00784-025-06252-1.
8
N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [F]FDG PET/CT compared to the histopathology reference standard.肺大细胞神经内分泌癌的N分期:[F]FDG PET/CT与组织病理学参考标准相比的诊断价值。
EJNMMI Res. 2021 Jul 22;11(1):68. doi: 10.1186/s13550-021-00811-9.
9
The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer.18F-FDG PET/CT在胃癌初始分期中的作用
Mol Imaging Radionucl Ther. 2015 Feb 5;24(1):15-20. doi: 10.4274/mirt.26349.
10
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?宫颈癌术前分期:18F-FDG-PET/CT 对早期宫颈癌患者真的有效吗?
Gynecol Oncol. 2011 Nov;123(2):236-40. doi: 10.1016/j.ygyno.2011.07.096. Epub 2011 Aug 19.

本文引用的文献

1
Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.局部晚期宫颈癌中 18F-FDG PET/CT 影像学的影响:文献综述。
Curr Oncol. 2024 Apr 29;31(5):2508-2526. doi: 10.3390/curroncol31050188.
2
Development and validation of a F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.开发和验证 F-FDG PET/CT 放射组学列线图预测局部晚期宫颈癌无进展生存期:一项回顾性多中心研究。
BMC Cancer. 2024 Jan 30;24(1):150. doi: 10.1186/s12885-024-11917-3.
3
Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
利用放射组学和机器学习结合磁共振成像预测局部晚期宫颈癌新辅助化疗的反应
Diagnostics (Basel). 2023 Oct 6;13(19):3139. doi: 10.3390/diagnostics13193139.
4
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.ESGO/ESTRO/ESP 宫颈癌管理指南-2023 年更新版。
Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429.
5
Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation.接受放化疗的晚期宫颈癌患者行外科性腹主动脉旁淋巴结分期的肿瘤学结局。
Int J Gynecol Cancer. 2022 Jul 4;32(7):823-827. doi: 10.1136/ijgc-2022-003394.
6
Cervical cancer therapies: Current challenges and future perspectives.宫颈癌治疗:当前的挑战与未来展望。
Tumour Virus Res. 2022 Jun;13:200238. doi: 10.1016/j.tvr.2022.200238. Epub 2022 Apr 20.
7
Implications of the revised cervical cancer FIGO staging system.修订版宫颈癌 FIGO 分期系统的意义。
Indian J Med Res. 2021 Aug;154(2):273-283. doi: 10.4103/ijmr.IJMR_4225_20.
8
Cancer of the cervix uteri: 2021 update.子宫颈癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.
9
Using rADioMIcs and machine learning with ultrasonography for the differential diagnosis of myometRiAL tumors (the ADMIRAL pilot study). Radiomics and differential diagnosis of myometrial tumors.应用放射组学和超声机器学习对子宫肌肿瘤进行鉴别诊断(ADMIRAL 初步研究)。放射组学与子宫肌肿瘤的鉴别诊断。
Gynecol Oncol. 2021 Jun;161(3):838-844. doi: 10.1016/j.ygyno.2021.04.004. Epub 2021 Apr 16.
10
Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.采用 MRI 对宫颈癌进行分期、复发和随访:FIGO 分期 2018 修订后欧洲泌尿生殖放射学会的更新指南。
Eur Radiol. 2021 Oct;31(10):7802-7816. doi: 10.1007/s00330-020-07632-9. Epub 2021 Apr 14.